Protective effects of phoenixin 14 from the pathological point of view in experimental duodenal ulcer induced by indomethacin in rats

Subject Areas : Journal of Comparative Pathobiology

یاسر Zandeh‑Rahimi ¹ ( 1- Department of Veterinary Basic Sciences, Science, Science and Research Branch, Islamic Azad University, Tehran, Iran )
نگار Panahi ² ( Department of Veterinary Basic Sciences, Science, Science and Research Branch, Islamic Azad University, Tehran, Iran. )
سعید Hesaraki ³ ( Department of Pathobiology, Science and Research Branch, Islamic Azad University, Tehran, Iran. )
S.H Shirazi‑Beheshtiha ⁴ ( Islamic Azad University, Karaj Branch, Faculty of Veterinary Medicine, Karaj, Iran )

Received: 2023-02-16 Accepted : 2023-04-28 Published : 2023-04-28

Keywords: Neuropeptide phenoxin-14, Duodenum, Indomethacin, Wound, inflammation,

Abstract :

Phoenixin-14 (PNX-14) is a newly identified neuropeptide with potential anti-inflammatory effects in the gastrointestinal tract. This study evaluated the protective effect of PNX-14 against the formation of duodenal ulcers caused by experimental indomethacin (IND). Thirty-two male Sprague-Dawley rats were randomly assigned to four groups. They include negative control, IND (7.5 mg/kg subcutaneous indomethacin), FAM (7.5 mg/kg subcutaneous indomethacin followed by 40 mg /kg famotidine intraperitoneal), and PNX-14 (7.5 mg/kg subcutaneous indomethacin followed by 50 μg/kg intraperitoneal PNX-14). Outcome measures included macroscopic assessment of duodenal lesions and histopathological parameters. Selected parts of the duodenum were removed and placed in 10% formalin, and hematoxylin and eosin staining were prepared. The macroscopic grade of duodenal lesions in the PNX-14 group was significantly smaller than the IND group (P< 0.001). The components of tissue pathology lesions were significantly increased in the IND group. The wound's diameter and depth and the inflammation intensity in the PNX-14 group were significantly smaller than in the IND group (P<0.001). PNX-14 was superior to the FAM group in reducing inflammation. PNX-14 showed significant protective effects against IND-induced duodenal ulcer formation. These results show a promising therapeutic outcome for PNX-14 in treating inflammatory disorders of the gastrointestinal tract.

References:

1.Kalkan Ö F, Şahin Z, Öztürk H, Keser H, Aydın-Abidin S, Abidin İ. Phoenixin-14 reduces the frequency of interictal-like events in mice brain slices. Exp Brain Res. 2021;239(9):2841-9.

2. Wang J, Zheng B, Yang S, Tang X, Wang J, Wei D. The protective effects of phoenixin-14 against lipopolysaccharide-induced inflammation and inflammasome activation in astrocytes. Inflamm Res. 2020;69(8):779-87.

3. Hazel K, O'Connor A. Emerging treatments for inflammatory bowel disease. Ther Adv Chronic Dis. 2020;11:2040622319899297.

4. Singh A, Zapata RC, Pezeshki A, Reidelberger RD, Chelikani PK. Inulin fiber dose-dependently modulates energy balance, glucose tolerance, gut microbiota, hormones and diet preference in high-fat-fed male rats. The Journal of nutritional biochemistry. 2018;59:142-52.

5. Mai N, Prifti V, Kim M, Halterman MW. Characterization of neutrophil-neuronal co-cultures to investigate mechanisms of post-ischemic immune-mediated neurotoxicity. Journal of neuroscience methods. 2020;341:108782.

6. Rocca C, Scavello F, Granieri M, Pasqua T, Amodio N, Imbrogno S, et al. Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection. Cellular and molecular life sciences. 2018;75(4):743-56.

7. Yang F, Huang P, Shi L, Liu F, Tang A, Xu S. Phoenixin 14 inhibits high-fat diet-induced non-alcoholic fatty liver disease in experimental mice. Drug Design, Development and Therapy. 2020;14:3865.

8. Pałasz A, Tyszkiewicz-Nwafor M, Suszka-Świtek A, Bacopoulou F, Dmitrzak-Węglarz M, Dutkiewicz A, et al. Longitudinal study on novel neuropeptides phoenixin, spexin and kisspeptin in adolescent inpatients with anorexia nervosa–association with psychiatric symptoms. Nutritional neuroscience. 2021;24(11):896-906.

9. Billert M, Rak A, Nowak KW, Skrzypski M. Phoenixin: More than Reproductive Peptide. International Journal of Molecular Sciences. 2020;21(21):8378.

10. Haber MM, Lopez I. Gastric histologic findings in patients with nonsteroidal anti-inflammatory drug-associated gastric ulcer. Mod Pathol. 1999;12(6):592-8.

11. Rao SS, Joffe SN. Histological grading and sequential morphological changes during the production of acute duodenal ulcers. Br J Exp Pathol. 1979;60(4):411-6.

12. Zandeh-Rahimi Y, Panahi N, Hesaraki S, Shirazi-Beheshtiha SH. Protective Effects of Phoenixin-14 Peptide in the Indomethacin-Induced Duodenal Ulcer: An Experimental Study. Int J Pept Res Ther. 2022;28(1):43.

13. Schalla MA, Stengel A. Phoenixin-A Pleiotropic Gut-Brain Peptide. Int J Mol Sci. 2018;19(6).

14. Sinagra E, Utzeri E, Morreale GC, Fabbri C, Pace F, Anderloni A. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians. World J Clin Cases. 2020;8(6):1013-25.

15. Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? npj Parkinson's Disease. 2017;3(1):3.

16. Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Ramirez VH, et al. European Crohn’s and Colitis Organisation Topical Review on Environmental Factors in IBD. Journal of Crohn's and Colitis. 2016;11(8):905-20.

17. Wei P, Keller C, Li L. Neuropeptides in gut-brain axis and their influence on host immunity and stress. Computational and Structural Biotechnology Journal. 2020;18:843-51.

18. Hansen JJ, Sartor RB. Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches. Current Treatment Options in Gastroenterology. 2015;13(1):105-20.

19. Chen WC, Liu YB, Liu WF, Zhou YY, He HF, Lin S. Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect. Front Immunol. 2020;11:580378.

20. Ozturk CC, Oktay S, Yuksel M, Akakin D, Yarat A, Kasimay Cakir O. Anti-inflammatory effects of nesfatin-1 in rats with acetic acid - induced colitis and underlying mechanisms. J Physiol Pharmacol. 2015;66(5):741-50.

21. Pałasz A, Rojczyk E, Bogus K, Worthington JJ, Wiaderkiewicz R. The novel neuropeptide phoenixin is highly co-expressed with nesfatin-1 in the rat hypothalamus, an immunohistochemical study. Neuroscience Letters. 2015;592:17-21.